Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

Following the successful identification of long-term previously invisible lung damage in post-Covid patients, a large NIHR grant will enable a University of Oxford team including DPAG's Dr James Grist to continue this crucial work to shed light on why people with confirmed Long Covid continue to experience breathlessness following recovery from Covid-19.

The healthy lungs appear to have more gas activity present than the post Covid scan which shows more dark areas indicating damage.

A University of Oxford trial has launched to detect hidden lunch damage in patients suffering from ongoing breathlessness following their recovery from Covid-19. Breathlessness is a common long-term symptom suffered by those with ‘Long Covid’, a condition that is still not fully understood, but can impact sufferers for many weeks or even months after recuperating from Covid-19, even if they did not require treatment in hospital for the disease.

The study, led by Professor Fergus Gleeson from the Department of Oncology, with a team of researchers including DPAG’s Dr James Grist, is one of 15 being funded by a £20 million research drive by the National Institute for Health Research (NIHR).

A new technique is enabling the team to detect previously invisible damage to the lungs, even when it does not show up on standard MRI or CT scans. Dr James Grist has been scanning and analysing the lungs of post-Covid patients at Churchill Hospital with hyperpolarised Xenon magnetic resonance imaging, which helped to uncover the extent of the damage that can be caused by the disease in otherwise healthy-looking lungs.

The new scans trace inhaled gas moving into and out of the lungs, and early work showed a dramatic decrease in the ability of the lungs to diffuse gas into the blood stream after COVID infection. With the new NIHR funding, Dr Grist will continue this work with patients who have confirmed Long Covid.

Dr Grist said “We hope that, with the visualisation of lung damage that is otherwise invisible to conventional imaging and physiological methods, we’ll be able to start trialling therapies to reverse the damage leading to breathlessness. Furthermore, this study has opened up the opportunity to detect invisible lung damage in patient with otherwise unexplained breathlessness - providing us new insights into lung physiology.” 

Read more on the BBC News website and The Guardian.

Similar stories

REF 2021 results

DPAG researchers showcased at premier European Society of Cardiology meeting

DPAG scientists across four research groups were highlighted at the major annual European Society of Cardiology basic science conference (FCVB 2022). Congratulations are in order for Dr KC Park on receiving the Young Investigator Award and to Dr Elisabetta Gamen on winning the Moderated Poster Prize.

Oxford Parkinson’s Disease Centre awarded £3.8 million to reveal the role of calcium in Parkinson’s

A collaborative research team led by the Oxford Parkinson’s Disease Centre (OPDC) has been awarded a £3.8 million Wellcome Trust Collaborative Award to study the function of calcium in dopamine neurons, and how this is plays a role in Parkinson’s. Their research will help explain how and why dopamine neurons are vulnerable in the disease and look at how they may be preserved.

DPAG Postdoctoral Researcher acknowledged for developmental and cell biology research

Dr Matthew Stower was selected to give an oral presentation of his work and his abstract won the second prize at the Joint Spring Meeting of the British Society for Developmental Biology (BSDB) and the British Society for Cell Biology (BSCB).

The effect of nuclear pH on cardiac gene expression

Research led by Dr Alzbeta Hulikova and Professor Pawel Swietach has, for the first time, described the potential regulation of nuclear acid-base chemistry in neonatal and adult cardiomyocytes, and explained its relevance in the context of heart physiology and pathology.